Myelofibrosis
A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/�L) (PAC203)
- Details
ClinicalTrials.gov ID:
NCT03165734
Diagnosis Type:
NA
USOR Number:
- Address
3550 N E Loop 286
Paris, TX 75460
P: (903) 785-0031